证券代码：002050 证券简称：三花智控 公告编号：2025-092 浙江三花智能控制股份有限公司 关于回购公司股份的进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 浙江三花智能控制股份有限公司（以下简称"公司"）于 2024 年 12 月 30 日 召开的第七届董事会第三十次临时会议，审议通过了《关于回购公司股份方案的 议案》。2025 年 1 月 8 日，公司披露了《回购股份报告书》（公告编号：2025-002）。 具体关于回购股份的信息详见在巨潮资讯网（http://www.cninfo.com.cn）和《证 券时报》《上海证券报》披露的相关公告。 公司使用自有资金及股票回购专项贷款资金以集中竞价交易方式回购公司 股份，回购的价格不超过人民币 36.00 元/股（因实施 2024 年度权益分派，回购 价格上限相应调整，实际的回购价格上限将不超过 35.75 元/股），回购的资金总 额为不低于人民币 30,000 万元且不超过人民币 60,000 万元，具体回购股份的数 量及占总股本的比例以回购期满时实际回购数量为准。本次回购股份的实施期限 为 ...

Core Viewpoint - The company, Sanhua Intelligent Control (02050.HK), announced a share buyback plan, indicating confidence in its stock value and commitment to returning capital to shareholders [1] Summary by Categories Share Buyback Details - As of September 30, 2025, the company repurchased 1.507 million shares, representing 0.0358% of its total share capital [1] - The highest transaction price during the buyback was 31.00 CNY per share, while the lowest was 22.69 CNY per share [1] - The total amount spent on the buyback was approximately 35.97 million CNY, excluding transaction fees [1] Compliance and Strategy - The buyback aligns with the company's established repurchase plan, reflecting its strategic approach to managing capital and enhancing shareholder value [1]

Core Viewpoint - Sanhua Intelligent Controls (02050) has made progress in its share repurchase plan, indicating a commitment to enhancing shareholder value through stock buybacks [1] Summary by Categories Share Repurchase Details - As of September 30, 2025, the company repurchased a total of 1.5068 million shares, which represents 0.0358% of the total share capital [1] - The highest transaction price during the repurchase was 31.00 CNY per share, while the lowest was 22.69 CNY per share [1] - The total amount spent on the repurchase was 35,971,525.86 CNY, excluding transaction fees [1] - This repurchase aligns with the company's established buyback plan [1]

Core Viewpoint - Sanhua Intelligent Control (002050) has made progress in its share repurchase plan, indicating a commitment to enhancing shareholder value through stock buybacks [1] Summary by Categories Share Repurchase Details - As of September 30, 2025, the company repurchased a total of 1.5068 million shares, which represents 0.0358% of the company's total share capital [1] - The highest transaction price during the repurchase was 31.00 CNY per share, while the lowest was 22.69 CNY per share [1] - The total amount spent on the repurchase was approximately 35,971,525.86 CNY, excluding transaction fees [1] Compliance with Repurchase Plan - The repurchase activities are in line with the company's established repurchase plan, reflecting a strategic approach to managing its capital structure [1]

Group 1 - The China Securities New Energy Vehicle Industry Index (930997) has seen a strong increase of 3.73% as of October 9, 2025, with notable gains from companies such as Dongsheng Technology (300073) up 11.76%, Ganfeng Lithium (002460) up 10.00%, and Tianqi Lithium (002466) up 9.31% [1] - The New Energy Vehicle ETF (515700) has risen by 3.63%, marking its third consecutive increase, with the latest price reported at 2.63 yuan. Over the past two weeks, the ETF has accumulated a rise of 6.92% [1] - The New Energy Vehicle ETF closely tracks the China Securities New Energy Vehicle Industry Index, which includes 50 listed companies involved in various sectors of the new energy vehicle industry, reflecting the overall performance of leading companies in this sector [1] Group 2 - As of September 30, 2025, the top ten weighted stocks in the China Securities New Energy Vehicle Industry Index include CATL (300750), Huichuan Technology (300124), BYD (002594), and others, collectively accounting for 54.61% of the index [2] - The weightings of the top stocks are as follows: CATL at 9.80%, Huichuan Technology at 9.63%, BYD at 9.10%, and Changan Automobile (000625) at 5.08% [4]

Core Insights - The Hong Kong IPO market experienced significant growth in the first three quarters of 2025, leading globally with 68 new listings and total fundraising of HKD 182.45 billion, representing a 51% and 227% increase year-on-year respectively [1][4] - The high demand for new shares is evident, with 98% of new stocks being oversubscribed and 86% having oversubscription multiples exceeding 20 times, doubling from the previous year [2][4] - The current market activity is characterized by healthy growth following regulatory changes that ended the era of high-leverage IPO subscriptions, shifting the focus to intrinsic value recognition and natural capital inflow [4][8] New Share Subscription Trends - In the first three quarters of 2025, 15 new stocks had oversubscription multiples exceeding 1,000 times, accounting for nearly 23% of new listings, with the highest being Daheng Technology at 7,558.40 times [2][3] - The pharmaceutical and durable consumer goods sectors saw the most interest, with several biotech firms achieving significant oversubscription rates, indicating strong investor confidence in innovative drug companies [2][3] Market Performance Metrics - The first-day IPO failure rate dropped to 24%, the lowest in nine years, with an average first-day return of 28%, a substantial increase from 10.82% in the previous year [5][6] - Notably, large IPOs performed exceptionally well, with companies like Ningde Times seeing a first-day increase of 16% and cumulative gains exceeding 87% by September 30 [7] Policy and Market Dynamics - The surge in the IPO market is attributed to a combination of policy benefits, ample liquidity, and industry upgrades, with regulatory measures simplifying the listing process and enhancing market attractiveness [8][9] - The Hong Kong Stock Exchange has received 348 listing applications as of October 5, 2025, with ongoing efforts to optimize regulations and attract more overseas companies [8][9] Industry Structure and Appeal - The IPO landscape in Hong Kong is driven by a dual focus on technology and consumer sectors, with the medical and pharmaceutical industries leading in the number of listings, while manufacturing accounted for over 30% of fundraising [9]

Core Insights - The Hong Kong IPO market has experienced significant growth in the first three quarters of 2025, leading globally with 68 new listings and total fundraising of HKD 182.45 billion, representing a 51% and 227% increase year-on-year, respectively [1][4] - The market has seen a high level of oversubscription, with 98% of new stocks being oversubscribed and 86% having oversubscription multiples exceeding 20 times, doubling from the previous year [1][4] - The decline in the first-day drop rate to 24% marks a nine-year low, with an average first-day return of 28%, significantly up from 10.82% in the previous year [6][7] Market Activity - A total of 15 new stocks had oversubscription multiples exceeding 1,000 times, accounting for nearly 23% of the new listings, with the highest being Daheng Technology at 7,558.40 times [2][3] - The pharmaceutical and durable consumer goods sectors have been particularly favored, with several biotech companies achieving high oversubscription rates, indicating strong investor interest in innovative drug companies [2][3] Regulatory Environment - The recent surge in market activity is attributed to a healthier growth environment following regulatory changes that ended the era of high-leverage IPO subscriptions, with the Hong Kong Securities and Futures Commission implementing measures to curb excessive leverage [4][5] - The previous year saw only 2 new stocks with oversubscription multiples exceeding 1,000 times, highlighting the shift in market dynamics post-regulation [4][5] Investment Returns - The significant increase in first-day returns and the reduction in the drop rate have contributed to a more favorable investment environment, attracting more investors to the IPO market [6][7] - The performance of large new listings, such as NIO's H-shares, which saw a first-day increase of 16% and a cumulative rise of over 87% by September 30, has further enhanced the appeal of IPO investments [6][7] Market Drivers - The robust performance of the Hong Kong IPO market is driven by a combination of policy incentives, ample liquidity, and an evolving industrial landscape, with the medical and pharmaceutical sectors leading in new listings [7][8] - The Hong Kong Stock Exchange has received 348 listing applications as of October 5, 2025, indicating strong interest from companies, particularly in the technology and consumer sectors [7][8]

Core Insights - Zijin Mining's subsidiary, Zijin Gold International, has successfully listed on the Hong Kong Stock Exchange, marking it as the second-largest IPO in Hong Kong this year [2][3] - The IPO attracted 29 cornerstone investors, including major insurance companies such as Taikang Life and China Pacific Insurance, highlighting the significant role of insurance capital in Hong Kong IPOs this year [1][3] Group 1: IPO Participation - Taikang Life has participated in at least five Hong Kong IPOs this year, with a total investment exceeding 1.4 billion HKD across various projects [2][3] - China Pacific Insurance has also been active in the IPO market, matching Taikang Life's investment scale in the same projects [3] - Other insurance companies, such as Dajia Life and China Post Life, have also made notable investments in recent IPOs, indicating a trend of increased participation from insurance capital [3] Group 2: Investment Strategies - Insurance capital is increasingly focusing on equity investments, not only in IPOs but also in the primary and secondary markets [4][5] - China Life has emerged as a strategic investor in the largest A-share IPO of the year, Huadian New Energy, showcasing the growing influence of insurance funds in various market segments [4] - Recent regulatory changes have improved the allocation advantages for insurance capital in IPOs, allowing them to secure a larger share of new offerings [5] Group 3: Market Performance - The performance of newly listed stocks has been favorable, with many IPOs achieving significant gains on their first trading day, such as Zijin Gold International, which rose over 68% [7] - The overall trend indicates that insurance capital has been able to realize substantial floating profits from their IPO investments, although the long-term profitability remains uncertain due to lock-up periods [7]

Group 1 - The trend of A-share companies listing in Hong Kong continues, with 25 companies announcing plans to list since September, including notable names like XinNuoWei and Lingyi ZhiZao [1] - As of October 2, a total of 76 companies have submitted listing applications to the Hong Kong Stock Exchange, covering various industries such as pharmaceuticals, communications, food and beverages, automotive, and machinery [3] - The fundraising scale has significantly increased, with 11 A-share companies raising a total of 916.89 million HKD through the "A+H" dual listing model, accounting for over 50% of this year's total IPO financing in Hong Kong [3] Group 2 - The CEO of the Hong Kong Stock Exchange noted a substantial increase in new stock issuance, with total financing reaching 1,345 million HKD by the end of August, nearly six times higher than the same period in 2024 [3] - The "A+H" listing model has shown strong performance, with related companies raising 70% of the total financing in the first half of the year, indicating a robust linkage between A-share and Hong Kong markets [3]

Core Points - The Hong Kong stock market closed with the Hang Seng Index rising by 1.61% and the Hang Seng Tech Index increasing by 3.36% [1] - The Hong Kong Tech ETF (159751) rose by 3.17%, while the Hang Seng Hong Kong Stock Connect ETF (159318) increased by 1.11% [1] Sector Performance - Semiconductor products and equipment, as well as metals and mining sectors, showed significant gains [1] - Conversely, passenger airlines and construction products sectors experienced notable declines [1] Individual Stock Movements - Notable gainers included Zijin Mining International, which rose by 14.01%, and SMIC, which increased by 12.7% [1] - Other significant gainers included Kelun-Botai Bio (+9.44%), Lens Technology (+9.19%), Kuaishou-W (+8.57%), and WuXi AppTec (+7.15%) [1] - Decliners included NetDragon, which fell by 6.14%, and Haotian International Construction Investment, which dropped by 11.11% [1] - Dazhong Public Utilities saw a substantial increase of 18.35%, while MIRXES-B rose by 17.1% [1]